InvestorsHub Logo
Followers 4
Posts 204
Boards Moderated 0
Alias Born 01/09/2017

Re: Mistral post# 19450

Sunday, 04/09/2017 7:53:56 PM

Sunday, April 09, 2017 7:53:56 PM

Post# of 73040
As you can see, I'm not the only person that sees Absorption Pharmaceuticals product, Promescent, as a leader in the PE market.

I never denied it. you were definitely saying that they were the only competition to be aware or keen of( youve changed your stance from only promescent as a singular leader, to saying it as a leader of many). and i quote "Promescent as the clear leader in the PE aspect of dysfunction" you are arguing with yourself. your argument is redundant.

Let's not prematurely claim ViaDerma's unveiled product a contender.

why wouldnt we say its a contender? is the product not going into the PE market? hmmmm maybe they will sell it to thin air.